Profil de tolérance de réintroduction en deux doses de l’Aspirine à doses anti-agrégantes

F. Laborier(Sorbonne Université), A. Soria(Inserm), F. Kurihara(Sorbonne Université), O. Bayrou, ML Soulié(Sorbonne Université), P. Mathelier‐Fusade(Sorbonne Université), A. Barbaud(Sorbonne Université), J.E. Autegarden(Sorbonne Université), A. Hamelin(Sorbonne Université), E. Amsler(Sorbonne Université), T. Haddad(Wake Forest University), H. Gaouar(Sorbonne Université)

Revue française d'allergologie

May 1, 2021

10.1016/j.reval.2021.03.135

Cited by 0

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

|Allergy|2018|1.5k

The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

|Allergy|2014|1.2k

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

|Dermatology Review|2015|429

The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA<sup>2</sup>LEN/EDF/UNEV consensus recommendations 2016 update and revision

|Allergy|2016|357

The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA<sup>2</sup>LEN/EDF/UNEV consensus panel recommendations

|Allergy|2009|162